Hitachi's SF-VA 100 paces new products

Article

The design of this Japanese vendor's new x-ray angiography systemhas been raising eyebrows since it was featured in a panel displayin the company's booth at the 1994 RSNA meeting. SF-VA 100 isa rotational angiography system, but it looks more like a CT

The design of this Japanese vendor's new x-ray angiography systemhas been raising eyebrows since it was featured in a panel displayin the company's booth at the 1994 RSNA meeting. SF-VA 100 isa rotational angiography system, but it looks more like a CT scanner,due to the gantry that houses the system's x-ray tube and assembly.

Hitachi will finally be able to test the commercial watersfor SF-VA 100 after receiving 510(k) clearance for the productthis summer. SF-VA 100 generates up to 288 views acquired in a360° rotation performed in five seconds. The digitized sequencemay be played back in subtracted or nonsubtracted modes to createa detailed 360° perspective of selected vasculature and surroundingstructures.

In MRI, enhancements for the open-style Airis and 1.5-teslaStratis will be the promotional focal points for Hitachi. Thecompany will highlight version 4.0 software for the 0.3-teslaAiris, which features image display and control panel refinements,improved fast spin-echo imaging, and fast fluid-attenuated inversionrecovery (Fast Flair), a sequence for fluid-suppressed T2-weightedimaging. The Stratis presentation will feature phased-array coilsand echo-planar imaging, according to Sheldon Schaffer, directorof marketing.

The ultrasound section of Hitachi's booth will feature EUB-525,a color-flow scanner. The system has been displayed at previousRSNA meetings, but Hitachi began shipments in August after receivingFDA clearance, according to Patrick Herguth, product manager forthe ultrasound division.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.